Results 101 to 110 of about 9,315 (166)

Pharmacokinetics of meprobamate in overdose treated with continuous venovenous hemodiafiltration (CVVHDF)

open access: yes, 2013
We report a case of massive suicidal overdose of meprobamate leading to cardiovascular collapse, respiratory failure, and severe central nervous system depression.
Alessandro Ceschi   +11 more
core   +1 more source

Enhanced cognitive outcomes with triple-mode dialysis in kidney failure: role of protein-bound toxin clearance

open access: yesRenal Failure
This study aimed to investigate the effects of different dialysis modalities on cognitive function in patients with end stage renal disease and to explore their association with the clearance of protein bound uremic toxins.
Maozhu Wang   +4 more
doaj   +1 more source

Hemodiafiltration treatment for high bilirubinemia state after hepatectomy

open access: yes, 2007
Hyperbilirubinemia which developed after right postoperative course of the patient and the effect of hepatectomy is reported in a 66-year-old male. The application of hemodiafiltration treatment in the postoperative course of the patient and the effect ...
Polat, Erdal   +5 more
core  

Advancing high-volume hemodiafiltration: from concept to CONVINCE

open access: yes
Conventional kidney replacement therapy (KRT) for end-stage kidney disease (ESKD) is associated with unmet medical needs, limited efficiency, poor patient outcomes, perception, and high costs. Advancements, including synthetic high-flux membranes, better-
Bernard Canaud
core   +1 more source

High-Volume Hemodiafiltration Versus High-Flux Hemodialysis: A Narrative Review for the Clinician

open access: yes
Background: End-stage kidney disease (ESKD) management presents a significant challenge, with increasing patient burden, escalating costs, and unmet needs in improving survival and quality of life.
Giovanni Strippoli   +2 more
core   +1 more source

Ten tips for the first hemodialysis sessions. [PDF]

open access: yesClin Kidney J
Hecking M   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy